E-LIB Suche - Ergebnisse für: Moussa, Samir

1

2138. In Vitro Susceptibility of Recent Clinical Isolates o..:

McLeod, Sarah ; Carter, Nicole ; Moussa, Samir.
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

2

518. Characterization of colistin-resistant (COL-R) Acineto..:

Moussa, Samir ; McLeod, Sarah ; Miller, Alita
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

3

COVID-19 effects on the going concern audit opinion in MENA..:

Feghali, Khalil ; Hallak, Joe ; Moussa, Samir
Risk Governance and Control: Financial Markets and Institutions. 12 (2022) 3 - p. 49-60 , 2022

Link: https://doi.org/10.22495..

4

1073. Sulbactam-Durlobactam Has Potent Activity Against Mul..:

Wannigama, Dhammika Leshan ; Higgins, Paul G ; Hurst, Cameron...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S628-S629 , 2021

Link: https://doi.org/10.1093/..

5

1293. Sulbactam-durlobactam is active against recent, multi..:

Miller, Alita ; McLeod, Sarah ; Moussa, Samir.
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S662-S662 , 2020

Link: https://doi.org/10.1093/..

6

1254. In vitro activity of sulbactam-durlobactam against re..:

McLeod, Sarah ; Moussa, Samir ; Hackel, Meredith.
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S644-S645 , 2020

Link: https://doi.org/10.1093/..

7

Sulbactam Combined With the Novel β-lactamase Inhibitor ETX..:

McLeod, Sarah ; Shapiro, Adam ; Moussa, Samir...
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016

Link: https://doi.org/10.1093/..

8

Characterization ofAcinetobacter baumannii-calcoaceticuscom..:

Miller, Alita A. ; Moussa, Samir H. ; McLeod, Sarah M..
Antimicrobial Agents and Chemotherapy. 68 (2024) 5 - p. , 2024

Link: https://doi.org/10.1128/..

9

Clinical Outcomes for Patients With Monomicrobial vs Polymi..:

McLeod, Sarah M ; Miller, Alita A ; Rana, Khurram...
Open Forum Infectious Diseases. 11 (2024) 4 - p. , 2024

Link: https://doi.org/10.1093/..

10

In Vivo Emergence of Pandrug-Resistant Acinetobacter bauman..:

VanNatta, Mollie ; Grier, Laurie ; Khan, Muhammad H...
Open Forum Infectious Diseases. 10 (2023) 10 - p. , 2023

Link: https://doi.org/10.1093/..

11

Molecular drivers of resistance to sulbactam-durlobactam in..:

Moussa, Samir H. ; Shapiro, Adam B. ; McLeod, Sarah M....
Antimicrobial Agents and Chemotherapy. 67 (2023) 11 - p. , 2023

Link: https://doi.org/10.1128/..

12

Comparative study between sleeve gastrectomy with cruroplas..:

Moussa, Samir Zohdy ; Sabry, Karim ; Maaty, Sameh Abd Allah.
International journal of health sciences. 6 (2022) S1 - p. 536-545 , 2022

Link: https://doi.org/10.53730..

13

Rational design of a new antibiotic class for drug-resistan..:

Durand-Reville, Thomas F. ; Miller, Alita A. ; O'Donnell, John P....
Nature. 597 (2021) 7878 - p. 698-702 , 2021

Link: https://doi.org/10.1038/..

14

Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor..:

Shapiro, Adam B. ; Moussa, Samir H. ; McLeod, Sarah M...
Frontiers in Microbiology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

15

The Structural Basis of T4 Phage Lysis Control: DNA as the ..:

Krieger, Inna V. ; Kuznetsov, Vladimir ; Chang, Jeng-Yih...
Journal of Molecular Biology. 432 (2020) 16 - p. 4623-4636 , 2020

Link: https://doi.org/10.1016/..